Tenaya Therapeutics
TNYA
89 hedge funds and large institutions have $19.3M invested in Tenaya Therapeutics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 38 closing their positions.
180% more call options, than puts
Call options by funds: $137K | Put options by funds: $49K
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
12.14% less ownership
Funds ownership: 31.52% → 19.37% (-12%)
17% less funds holding
Funds holding: 107 → 89 (-18)
30% less capital invested
Capital invested by funds: $27.7M → $19.3M (-$8.44M)
47% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$492K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$343K |
| 3 |
Millennium Management
New York
|
+$325K |
| 4 |
Jane Street
New York
|
+$182K |
| 5 |
Renaissance Technologies
New York
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$3.37M |
| 2 |
CC
Casdin Capital
New York
|
-$3.24M |
| 3 |
JP Morgan Chase
New York
|
-$1.29M |
| 4 |
BlackRock
New York
|
-$1.28M |
| 5 |
VA
VR Adviser
New York
|
-$887K |
TNYA Hedge Fund Activity: Q2 2025 in Review
89 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q2 2025, worth a combined $19.3M — down 30% from $27.7M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of TNYA and 20 opened new positions — a net loss of 18 holders — while 23 trimmed existing stakes and 25 added.
The largest buyer was AQR Capital Management, adding an estimated $492K. The largest seller was Woodline Partners, exiting entirely with an estimated $3.37M sold.
- 89 institutional investors held Tenaya Therapeutics (TNYA) as of Q2 2025, down from 107 in Q1 2025.
- Funds reported $19.3M of Tenaya Therapeutics stock for Q2 2025, down 30% quarter-over-quarter.
- 20 funds opened new Tenaya Therapeutics positions in Q2 2025 and 38 closed out, a net change of -18 holders.
- The largest Tenaya Therapeutics buyer in Q2 2025 was AQR Capital Management, an estimated $492K added.
- The largest Tenaya Therapeutics seller in Q2 2025 was Woodline Partners, an estimated $3.37M sold.
Based on aggregated 13F filings for Q2 2025.